Petersen Per H, Lund Flemming, Fraser Callum G, Sölétormos György
1 Department of Clinical Biochemistry, North Zealand Hospital, University of Copenhagen, Hillerød, Denmark.
2 Norwegian Quality Improvement of Primary Care Laboratories (NOKLUS), Section for General Practice, University of Bergen, Bergen, Norway.
Ann Clin Biochem. 2016 Nov;53(6):686-691. doi: 10.1177/0004563216634376. Epub 2016 Sep 28.
Background The distributions of within-subject biological variation are usually described as coefficients of variation, as are analytical performance specifications for bias, imprecision and other characteristics. Estimation of specifications required for reference change values is traditionally done using relationship between the batch-related changes during routine performance, described as Δbias, and the coefficients of variation for analytical imprecision (CV): the original theory is based on standard deviations or coefficients of variation calculated as if distributions were Gaussian. Methods The distribution of between-subject biological variation can generally be described as log-Gaussian. Moreover, recent analyses of within-subject biological variation suggest that many measurands have log-Gaussian distributions. In consequence, we generated a model for the estimation of analytical performance specifications for reference change value, with combination of Δbias and CV based on log-Gaussian distributions of CV as natural logarithms. The model was tested using plasma prolactin and glucose as examples. Results Analytical performance specifications for reference change value generated using the new model based on log-Gaussian distributions were practically identical with the traditional model based on Gaussian distributions. Conclusion The traditional and simple to apply model used to generate analytical performance specifications for reference change value, based on the use of coefficients of variation and assuming Gaussian distributions for both CV and CV, is generally useful.
受试者内生物变异的分布通常用变异系数来描述,偏差、不精密度和其他特性的分析性能规范也是如此。传统上,参考变化值所需规范的估计是利用常规检测过程中批次相关变化(描述为Δ偏差)与分析不精密度变异系数(CV)之间的关系进行的:最初的理论基于假设分布为高斯分布时计算的标准差或变异系数。方法:受试者间生物变异的分布通常可描述为对数高斯分布。此外,最近对受试者内生物变异的分析表明,许多被测量物具有对数高斯分布。因此,我们生成了一个基于CV作为自然对数的对数高斯分布,结合Δ偏差和CV来估计参考变化值分析性能规范的模型。以血浆催乳素和葡萄糖为例对该模型进行了测试。结果:使用基于对数高斯分布的新模型生成的参考变化值分析性能规范与基于高斯分布的传统模型实际相同。结论:基于变异系数的使用且假设CV和CV均为高斯分布,用于生成参考变化值分析性能规范的传统且易于应用的模型通常是有用的。